These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 12691838)

  • 1. Antipsychotic drug interactions with specific [3H]ketanserin binding sites in membrane fragments derived from human prefrontal cortex and human amygdala.
    Andorn AC; Bennett TL; Gallagher KK; Hogan D
    Brain Res; 2003 May; 971(1):66-72. PubMed ID: 12691838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects.
    Muguruza C; Moreno JL; Umali A; Callado LF; Meana JJ; González-Maeso J
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):852-64. PubMed ID: 23176747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]ketanserin binding in human brain postmortem.
    Marazziti D; Rossi A; Palego L; Giannaccini G; Naccarato A; Lucacchini A; Cassano GB
    Neurochem Res; 1997 Jun; 22(6):753-7. PubMed ID: 9178960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential distribution of [3H]sumatriptan binding sites (5-HT1B, 5-HT1D and 5-HT1F receptors) in human brain: focus on brainstem and spinal cord.
    Castro ME; Pascual J; Romón T; del Arco C; del Olmo E; Pazos A
    Neuropharmacology; 1997; 36(4-5):535-42. PubMed ID: 9225278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex.
    Dean B; Hussain T; Hayes W; Scarr E; Kitsoulis S; Hill C; Opeskin K; Copolov DL
    J Neurochem; 1999 Apr; 72(4):1593-9. PubMed ID: 10098866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of lipid peroxidation on [3H]ketanserin binding to 5-HT2 prefrontal cortex receptors.
    Rego AC; Oliveira CR
    Neurochem Int; 1995 Dec; 27(6):489-96. PubMed ID: 8574178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin2 receptors and the serotonin transporter in the schizophrenic brain.
    Dean B; Hayes W; Opeskin K; Naylor L; Pavey G; Hill C; Keks N; Copolov DL
    Behav Brain Res; 1996; 73(1-2):169-75. PubMed ID: 8788497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
    Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA; Davis KH; Titeler M
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in ketanserin binding in the ventromedial hypothalamus of ewes responsive or refractory to short days.
    Le Corre S; Segu L; Caldani M; Chemineau P
    Neuroendocrinology; 1994 Dec; 60(6):589-600. PubMed ID: 7700502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]-ketanserin binding sites in different psychiatric disorders.
    Marazziti D; Giannaccini G; Giromella A; Betti L; Pesce D; Nardi I; Rossi A; Lucacchini A; Cassano GB
    Neurochem Int; 2003 May; 42(6):511-6. PubMed ID: 12547650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]ketanserin labels serotonin 5-HT2 and alpha 1-adrenergic receptors in human brain cortex.
    Hoyer D; Vos P; Closse A; Palacios JM; Engel G; Davies H
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S48-50. PubMed ID: 2446070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-serotonergic 3H-ketanserin binding sites in human platelets: characteristics and interaction with calcium antagonists.
    Oliva D; Pocchiari F; Allievi L; Rovati GE; Nicosia S
    Pharmacol Res; 1992 Sep; 26(2):187-99. PubMed ID: 1409259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala.
    Hrdina PD; Demeter E; Vu TB; Sótónyi P; Palkovits M
    Brain Res; 1993 Jun; 614(1-2):37-44. PubMed ID: 8348328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of S2-receptor binding sites on cat blood platelets using [3H]ketanserin.
    Leysen JE; Gommeren W; De Clerck F
    Eur J Pharmacol; 1983 Mar; 88(1):125-30. PubMed ID: 6852103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AT-1015, a newly synthesized 5-HT2 receptor antagonist, dissociates slowly from the 5-HT2 receptor sites in rabbit cerebral cortex membrane.
    Rashid M; Watanabe M; Nakazawa M; Nagatomo T
    J Pharm Pharmacol; 2002 Aug; 54(8):1123-8. PubMed ID: 12195828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilized ketanserin binding sites from pig platelet membranes.
    Wesemann W; Hoffmann D
    Thromb Res; 1985 Sep; 39(6):693-700. PubMed ID: 2934860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization and pharmacological characterization of [3H]perospirone-binding sites in rat brain.
    Tanaka H; Ohno Y; Nakamura M
    Gen Pharmacol; 1998 Jul; 31(1):159-64. PubMed ID: 9595296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.